Ataxia and secretory diarrhea: Two unusual paraneoplastic syndromes occurring concurrently in the same patient with ganglioneuroblastoma

Journal of Pediatric Hematology/Oncology

Volumn 26, Issue 9, 2004, Pages 549-552

  Gesundheit, Benjamin ^a,b   Smith, Charles R ^b   Gerstle, J Ted ^b   Weitzman, Sheila S ^b   Chan, Helen S L ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Ganglioneuroblastoma; Neuroblastoma; Opsoclonus myoclonus ataxia; Paraneoplastic syndrome; Vasoactive intestinal peptide

Indexed keywords

ADRENALIN; ANTIBODY; DNA; DOPAMINE; FERRITIN; HOMOVANILLIC ACID; IMMUNOGLOBULIN G; LACTATE DEHYDROGENASE; NORADRENALIN; PREDNISONE; VANILMANDELIC ACID; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADRENAL TUMOR; ARTICLE; ATAXIA; CASE REPORT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; ECHOGRAPHY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; IMMUNOHISTOCHEMISTRY; MYOCLONUS; NEUROBLASTOMA; OPSOCLONUS; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; RADIOGRAPHY;

ADRENAL GLAND NEOPLASMS; ATAXIA; DIARRHEA; FEMALE; GANGLIONEUROBLASTOMA; HUMANS; INFANT; LYMPHATIC METASTASIS; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; VASOACTIVE INTESTINAL PEPTIDE;

EID: 4544286861     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mph.0000139414.66455.a4     Document Type: Article

References (17)

1. Antunes NL, Khakoo Y, Matthay KK, et al. Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus. J Pediatr Hematol Oncol. 2000;22:315-320.
2. Hayward K, Jeremy RJ, Jenkins S, et al. Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies. J Pediatr. 2001;139:552-559.
3. Rudnick E, Khakoo Y, Antunes NL, et al. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies - a report from the Children's Cancer Group Study. Med Pediatr Oncol. 2001;36:612-622.
4. Matthay KK, Sather HN, Seeger RC, et al. Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol. 1989;7:236-244.
5. Kinsbourne M. Myoclonic encephalopathy of infants. J Neurol Neurosurg Psychiatry. 1962;25:271-276.
6. Solomon GE, Chutorian AM. Opsoclonus and occult neuroblastoma. N Engl J Med. 1968;279:475-477.
7. Cooper R, Khakoo Y, Matthay KK, et al. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features - a report from the Children's Cancer Group. Med Pediatr Oncol. 2001;36:623-629.
8. Russo C, Cohn SL, Petruzzi MJ, et al. Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group. Med Pediatr Oncol. 1997;28:284-288.
9. Petruzzi MJ, de Alarcon PA. Neuroblastoma-associated opsoclonus-myoclonus treated with intravenously administered immune globulin G. J Pediatr. 1995;127:328-329.
10. Verner JV, Morrison AB. Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. JAMA. 1958;25:374-380.
11. Green M, Cooke RE, Lattanzi W. Occurrence of chronic diarrhea in three patients with ganglioneuromas. Pediatrics. 1959;23:951-955.
12. Goossens JF, Manechez D, Pommery N, et al. VIP potentiates retinoic-acid effect on tissue transglutaminase activity in human neuroblastoma, the SK-N-SH cells. Neuropeptides. 1993;24:99-103.
13. Tanaka T, Hiyama E, Sugimoto T, et al. Trk A gene expression in neuroblastoma: the clinical significance of an immunohistochemical study. Cancer. 1995;76:1086-1095.
14. Eggert A, Ikegaki N, Liu XG, et al. Prognostic and biological role of neurotrophin-receptor Trk A and Trk B in neuroblastoma. Klin Paediatr. 2000:212:200-205.
15. Hill JM, Mehnert J, McCune SK, et al. Vasoactive intestinal peptide regulation of nerve growth factor in the embryonic mouse. Peptides. 2002;23:1803-1808.
16. Pence JC, Shorter NA. In vitro differentiation of human neuroblastoma cells caused by vasoactive intestinal peptide. Cancer Res. 1990;50:5177-5183.
17. Qualman SJ, O'Dorisio MS, Fleshman DJ, et al. Neuroblastoma. Correlation of neuropeptide expression in tumor tissue with other prognostic factors. Cancer. 1992;70:2005-2012.